Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Int Urol Nephrol ; 56(2): 667-674, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37458929

ABSTRACT

BACKGROUND: Statin use before hospitalization or after discharge increased the survival rates of patients with dialysis-requiring acute kidney injury. This study aimed to investigate whether statin use during hospitalization period after renal replacement therapy is associated with reduced mortality in patients with dialysis-requiring acute kidney injury. METHODS: This retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV database between 2008 and 2019. We compared 1-year mortality in patients with dialysis-requiring acute kidney injury with and without exposure to statin during hospitalization period after renal replacement therapy. The secondary outcome was in-hospital mortality. RESULTS: Among 1035 patients with dialysis-requiring acute kidney injury, only 24.9% of the participants received statin therapy during hospitalization after renal replacement therapy. During the 1-year follow-up, 127 of 258 statin users (49.2%) and 541 of 777 statin nonusers (69.6%) died. The risk of 1-year mortality and in-hospital mortality of statin users was 54% lower [hazard ratio (HR) = 0.46; 95% confidence interval (CI) = 0.37 to 0.56, P < 0.001] and 59% lower HR = 0.41, 95% CI = 0.32 to 0.53, P < 0.001), respectively. CONCLUSION: For patients with dialysis-requiring acute kidney injury, statin therapy during hospitalization period after renal replacement therapy was associated with decreased 1-year mortality and in-hospital mortality.


Subject(s)
Acute Kidney Injury , Hydroxymethylglutaryl-CoA Reductase Inhibitors , Humans , Renal Dialysis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Retrospective Studies , Renal Replacement Therapy , Acute Kidney Injury/therapy
2.
Int Urol Nephrol ; 56(5): 1773, 2024 May.
Article in English | MEDLINE | ID: mdl-37861892
3.
Int J Cell Biol ; 2022: 4416611, 2022.
Article in English | MEDLINE | ID: mdl-36483979

ABSTRACT

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, and there is currently a lack of effective treatment options to control the metastasis. This study was performed to examine the mechanisms of the migration and invasion characteristics of HCC, with the aim of reducing metastasis by inhibiting cancer cell migration and invasion. In this study, we used Stellettin B, an active compound isolated from Stelletta sponges, as the experimental drug and evaluated its inhibition effects on cell migration and invasion in human hepatoma cells (HA22T and HepG2). MTT assay, gelatin zymography, and western blotting were employed. The results showed that Stellettin B significantly inhibited the protein expressions of MMP-2, MMP-9, and uPA, while upregulating the protein expressions of TIMP-1 and TIMP-2. The expressions of p-FAK, p-PI3K, p-AKT, p-mTOR, and MAPKs (p-JNK, p-JUN, p-MAPKp38, and p-ERK) were decreased with increasing concentrations of Stellettin B. Our results suggest that Stellettin B-dependent downregulation of MMP-2 and MMP-9 activities could be mediated by FAK/PI3K/AKT/mTOR and MAPKs signaling pathways in HA22T and HepG2 cells, preventing HCC invasion and migration.

4.
Int J Mol Sci ; 22(14)2021 Jul 07.
Article in English | MEDLINE | ID: mdl-34298911

ABSTRACT

Osteoarthritis (OA) is the most common articular degenerative disease characterized by chronic pain, joint inflammation, and movement limitations, which are significantly influenced by aberrant epigenetic modifications of numerous OA-susceptible genes. Recent studies revealed that both the abnormal activation and differential expression of histone deacetylases (HDACs) might contribute to OA pathogenesis. In this study, we investigated the chondroprotective effects of a marine-derived HDAC inhibitor, panobinostat, on anterior cruciate ligament transection (ACLT)-induced experimental OA rats. The intra-articular administration of 2 or 10 µg of panobinostat (each group, n = 7) per week from the 6th to 17th week attenuates ACLT-induced nociceptive behaviors, including secondary mechanical allodynia and weight-bearing distribution. Histopathological and microcomputed tomography analysis showed that panobinostat significantly prevents cartilage degeneration after ACLT. Moreover, intra-articular panobinostat exerts hypertrophic effects in the chondrocytes of articular cartilage by regulating the protein expressions of HDAC4, HDAC6, HDAC7, runt-domain transcription factor-2, and matrix metalloproteinase-13. The study indicated that HDACs might have different modulations on the chondrocyte phenotype in the early stages of OA development. These results provide new evidence that panobinostat may be a potential therapeutic drug for OA.


Subject(s)
Anterior Cruciate Ligament/drug effects , Cartilage, Articular/drug effects , Chondrocytes/drug effects , Histone Deacetylase Inhibitors/pharmacology , Osteoarthritis, Knee/drug therapy , Pain/drug therapy , Panobinostat/pharmacology , Animals , Anterior Cruciate Ligament/metabolism , Anterior Cruciate Ligament Injuries/drug therapy , Anterior Cruciate Ligament Injuries/metabolism , Cartilage Diseases/drug therapy , Cartilage Diseases/metabolism , Cartilage, Articular/metabolism , Chondrocytes/metabolism , Disease Models, Animal , Male , Osteoarthritis, Knee/metabolism , Pain/metabolism , Rats , Rats, Wistar , Weight-Bearing
5.
Mar Drugs ; 18(6)2020 Jun 15.
Article in English | MEDLINE | ID: mdl-32549236

ABSTRACT

Hepatocellular carcinoma (HCC) is the most common liver or hepatic cancer, accounting for 80% of all cases. The majority of this cancer mortality is due to metastases, rather than orthotopic tumors. Therefore, the inhibition of tumor metastasis is widely recognized as the key strategy for successful intervention. A cembrane-type diterpene, flaccidoxide-13-acetate, isolated from marine soft coral Sinularia gibberosa, has been reported to have inhibitory effects against RT4 and T24 human bladder cancer invasion and cell migration. In this study, we investigated its suppression effects on tumor growth and metastasis of human HCC, conducting Boyden chamber and Transwell assays using HA22T and HepG2 human HCC cell lines to evaluate invasion and cell migration. We utilized gelatin zymography to determine the enzyme activities of matrix metalloproteinases MMP-2 and MMP-9. We also analyzed the expression levels of MMP-2 and MMP-9. Additionally, assays of tissue inhibitors of metalloproteinase-1/2 (TIMP-1/2), the focal adhesion kinase (FAK)/phosphatidylinositide-3 kinases (PI3K)/Akt/mammalian target of the rapamycin (mTOR) signaling pathway, and the epithelial-mesenchymal transition (EMT) process were performed. We observed that flaccidoxide-13-acetate could potentially inhibit HCC cell migration and invasion. We postulated that, by inhibiting the FAK/PI3K/Akt/mTOR signaling pathway, MMP-2 and MMP-9 expressions were suppressed, resulting in HCC cell metastasis. Flaccidoxide-13-acetate was found to inhibit EMT in HA22T and HepG2 HCC cells. Our study results suggested the potential of flaccidoxide-13-acetate as a chemotherapeutic candidate; however, its clinical application for the management of HCC in humans requires further research.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Diterpenes/pharmacology , Liver Neoplasms/drug therapy , Animals , Anthozoa/chemistry , Carcinoma, Hepatocellular/secondary , Cell Line, Tumor , Cell Movement/drug effects , Diterpenes/therapeutic use , Drug Screening Assays, Antitumor , Epithelial-Mesenchymal Transition/drug effects , Humans , Liver Neoplasms/pathology , Neoplasm Invasiveness/pathology , Neoplasm Invasiveness/prevention & control , Signal Transduction/drug effects
6.
Mar Drugs ; 16(4)2018 Mar 26.
Article in English | MEDLINE | ID: mdl-29587440

ABSTRACT

The 7-Acetylsinumaximol B (7-AB), a bioactive cembranoid, was originally discovered from aquaculture soft coral Sinularia sandensis. The current study investigated the anti-proliferative property of 7-AB towards the NCI-N87 human gastric cancer cell line. An MTT cell proliferative assay was applied to evaluate cell survival, and immunofluorescence staining and western blotting were employed to analyze the effects of 7-AB on autophagy and apoptosis. Our results showed that 7-AB exerted a concentration-dependent anti-proliferative effect on NCI-N87 cells, and fluorescence staining indicated that the effect was due to the apoptosis induced by 7-AB. In addition, the 7-AB-induced anti-proliferation towards NCI-N87 cells was associated with the release of cytochrome c from mitochondria, activation of pro-apoptotic proteins (such as caspase-3/-9, Bax and Bad), and inhibition of anti-apoptotic proteins (Bcl-2, Bcl-xL, and Mcl-1). The 7-AB treatment also triggered endoplasmic reticulum (ER) stress, leading to activation of the PERK/elF2α/ATF4/CHOP apoptotic pathway. Furthermore, 7-AB initiated autophagy in NCI-N87 cells and induced the expression of autophagy-related proteins, including Atg3, Atg5, Atg7, Atg12, LC3-I, and LC3-II. Taken together, our findings suggested that 7-AB has the potential to be further developed as a useful anti-cancer or adjuvant agent for the treatment of human gastric cancer.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Carcinoma/drug therapy , Diterpenes/pharmacology , Mitochondria/drug effects , Stomach Neoplasms/drug therapy , Activating Transcription Factor 4/genetics , Activating Transcription Factor 4/metabolism , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Eukaryotic Initiation Factor-2/genetics , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Humans , Molecular Structure , Signal Transduction/drug effects , Signal Transduction/physiology , Transcription Factor CHOP/genetics , Transcription Factor CHOP/metabolism , eIF-2 Kinase/genetics , eIF-2 Kinase/metabolism
7.
Environ Toxicol ; 32(4): 1290-1304, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27444805

ABSTRACT

Cell cycle regulation is an important issue in cancer therapy. Delphinidin and cyanidin are two major anthocyanins of the roselle plant (Hibiscus sabdariffa). In the present study, we investigated the effect of Hibiscus anthocyanins (HAs) on cell cycle arrest in human leukemia cell line HL-60 and the analyzed the underlying molecular mechanisms. HAs extracted from roselle calyces (purity 90%) markedly induced G2/M arrest evaluated with flow cytometry analysis. Western blot analyses revealed that HAs (0.1-0.7 mg mL-1 ) induced G2/M arrest via increasing Tyr15 phosphorylation of Cdc2, and inducing Cdk inhibitors p27 and p21. HAs also induced phosphorylation of upstream signals related to G2/M arrest such as phosphorylation of Cdc25C tyrosine phosphatase at Ser216, increasing the binding of pCdc25C with 14-3-3 protein. HAs-induced phosphorylation of Cdc25C could be activated by ATM checkpoint kinases, Chk1, and Chk2. We first time confirmed that ATM-Chk1/2-Cdc25C pathway as a critical mechanism for G2/M arrest in HAs-induced leukemia cell cycle arrest, indicating that this compound could be a promising anticancer candidate or chemopreventive agents for further investigation. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 1290-1304, 2017.


Subject(s)
Anthocyanins/pharmacology , G2 Phase Cell Cycle Checkpoints/drug effects , Hibiscus/chemistry , M Phase Cell Cycle Checkpoints/drug effects , Signal Transduction/drug effects , Tumor Suppressor Protein p53/genetics , 14-3-3 Proteins/metabolism , Anthocyanins/chemistry , Anthocyanins/isolation & purification , Ataxia Telangiectasia Mutated Proteins/metabolism , CDC2 Protein Kinase/metabolism , Cell Survival/drug effects , Checkpoint Kinase 1/metabolism , Checkpoint Kinase 2/metabolism , HL-60 Cells , Hibiscus/metabolism , Humans , Leukemia/metabolism , Leukemia/pathology , Phosphorylation/drug effects , Plant Extracts/chemistry , Tumor Suppressor Protein p53/deficiency , cdc25 Phosphatases/metabolism
8.
Chem Pharm Bull (Tokyo) ; 64(10): 1519-1522, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-27489045

ABSTRACT

A new 10-demethylated steroid, nephtheasteroid A (1), a new 19-oxygenated steroid, nephtheasteroid B (2) as well as five known steroids 3-7 were isolated from the organic extract of a Taiwanese soft coral Nephthea erecta. The structure was determined by means of IR, MS, and NMR techniques. Among these metabolites, 1 is rarely found in steroids possessing a 19-norergostane skeleton. In vitro cytotoxicity study using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that compounds 3 and 4 exhibited cytotoxicity against human chronic myelogenous leukemia (K562), human acute lymphoblastic leukemia (Molt-4), human T lymphoblastoid (Sup-T1), and human leukemic monocyte lymphoma (U937), with IC50 of 6.5-14.0 µM.


Subject(s)
Anthozoa/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Steroids/pharmacology , Sterols/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/isolation & purification , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Conformation , Steroids/chemistry , Steroids/isolation & purification , Sterols/chemistry , Sterols/isolation & purification , Structure-Activity Relationship
9.
J Agric Food Chem ; 63(32): 7211-8, 2015 Aug 19.
Article in English | MEDLINE | ID: mdl-26260702

ABSTRACT

New cembranoids 4-carbomethoxyl-10-epigyrosanoldie E (1), 7-acetylsinumaximol B (2), diepoxycembrene B (6), dihydromanaarenolide I (8), and isosinulaflexiolide K (9), along with 11 known related metabolites, were isolated from cultured soft corals Sinularia sandensis and Sinularia flexibilis. The structures were elucidated by means of infrared, mass spectrometry, and nuclear magnetic resonance techniques, and the absolute configurations of 1, 4, 9, and 15 were further confirmed by single-crystal X-ray diffraction analysis. The absolute configurations of these coral metabolites and comparison with known analogues showed that one hypothesis (that cembrane diterpenes possessing an absolute configuration of an isopropyl group at C1 obtained from Alcyonacean soft corals belong to the α series, whereas analogues isolated from Gorgonacean corals belong to the ß series) is not applicable for a small number of cembranoids. An in vitro anti-inflammatory study using LPS-stimulated macrophage-like cell line RAW 264.7 revealed that compounds 9-14 significantly suppressed the accumulation of pro-inflammatory proteins, iNOS and COX-2. Structure-activity relationship analysis indicated that cembrane-type compounds with one seven-membered lactone moiety at C-1 are potential anti-inflammatory agents. This is the first culture system in the world that has successfully been used to farm S. sandensis.


Subject(s)
Anthozoa/chemistry , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Diterpenes/chemistry , Diterpenes/pharmacology , Animals , Cyclooxygenase 2/genetics , Cyclooxygenase 2/immunology , Macrophages/drug effects , Macrophages/enzymology , Macrophages/immunology , Mice , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/immunology , RAW 264.7 Cells , Structure-Activity Relationship
10.
J Agric Food Chem ; 62(7): 1572-80, 2014 Feb 19.
Article in English | MEDLINE | ID: mdl-24471438

ABSTRACT

A previous study reported that anthocyanins from roselle (Hibiscus sabdariffa L.) showed significant anticancer activity in human promyelocytic leukemia cells. To explore the antitumor effect of anthocyanin, a roselle bioactive polyphenol in a rat model of chemical-induced leukemia was assayed. Anthocyanin extract of roselle (Hibiscus anthocyanins, HAs) was supplemented in the diet (0.1 and 0.2%). This study was carried out to evaluate the protective effect of HAs on N-nitrosomethylurea (NMU)-induced leukemia of rats. The study employed male Sprague-Dawley rats (n = 48), and leukemia was induced by intravenous injection of 35 mg kg(-1) body weight of NMU dissolved in physiologic saline solution. The rats were divided into four groups (n = 12): control, NMU only, and HAs groups that received different doses of HAs (0.1 and 0.2%) daily, orally, after NMU injection. After 220 days, the animals were killed, and the following parameters were assessed: morphological observation, hematology examination, histopathological assessment, and biochemical assay. When compared with the NMU-only group, HAs significantly prevented loss of organ weight and ameliorated the impairment of morphology, hematology, and histopathology. Treatment with HAs caused reduction in the levels of AST, ALT, uric acid, and MPO. Also, the results showed that oral administration of HAs (0.2%) remarkably inhibited progression of NMU-induced leukemia by approximately 33.3% in rats. This is the first report to demonstrate that the sequential administration of HAs followed by NMU resulted in an antileukemic activity in vivo.


Subject(s)
Anthocyanins/administration & dosage , Hibiscus/chemistry , Leukemia/prevention & control , Plant Extracts/administration & dosage , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Humans , Leukemia/drug therapy , Male , Methylnitrosourea/adverse effects , Rats , Rats, Sprague-Dawley
11.
Mar Drugs ; 11(1): 114-23, 2013 Jan 10.
Article in English | MEDLINE | ID: mdl-23306171

ABSTRACT

A new spatane diterpenoid, leptoclalin A (1), along with two previously reported known norcembranoid diterpenes (2 and 3), were isolated from a cultured soft coral Sinularia leptoclados. The structures were determined by extensive spectroscopic analyses and by comparison with the spectral data of related known compounds. Metabolite 1 is rarely found in spatane skeletons reported from soft corals. In addition, compound 1 exhibited weak cytotoxicity towards human tumor cell lines T-47 D and K-562.


Subject(s)
Anthozoa/chemistry , Diterpenes/chemistry , Diterpenes/pharmacology , Animals , Cell Line, Tumor , Humans , K562 Cells , Magnetic Resonance Spectroscopy/methods , Neoplasms/drug therapy
12.
Ren Fail ; 30(9): 939-42, 2008.
Article in English | MEDLINE | ID: mdl-18925535

ABSTRACT

A female concurrently developed polymyositis (PM), lung cancer, and nephrotic range proteinuria. Renal biopsy revealed crescentic glomerulonephritis. Pathology of lung cancer was proved to be adenocarcinoma. After surgical treatment of lung cancer, the symptoms of PM-associated crescentic glomerulonephritis disappeared. PM is associated with a higher risk of malignancy, though renal involvement in patients with PM is thought to be uncommon. In patients with PM, there have been few reports concerning the coexistence of glomerular disease, including crescent glomerulonephritis. Herein we report a case of crescentic glomerulonephritis-associated PM that was successfully treated after the surgical removal of lung cancer. We consider that such association of PM and crescent glomerulonephritis is rare in adults. Careful evaluation of underlying malignancy is important. The definite treatment is adequate management of underlying malignancy.


Subject(s)
Adenocarcinoma/diagnosis , Glomerulonephritis/etiology , Lung Neoplasms/diagnosis , Paraneoplastic Syndromes/diagnosis , Paraneoplastic Syndromes/etiology , Polymyositis/etiology , Adenocarcinoma/complications , Adenocarcinoma/surgery , Aged , Female , Glomerulonephritis/diagnosis , Glomerulonephritis/therapy , Humans , Lung Neoplasms/complications , Lung Neoplasms/surgery , Paraneoplastic Syndromes/therapy , Polymyositis/diagnosis , Polymyositis/therapy
13.
Ren Fail ; 30(7): 755-8, 2008.
Article in English | MEDLINE | ID: mdl-18704825

ABSTRACT

We report a case of primary Sjogren's syndrome (SS) with cutaneous leukocytoclastic vasculitis and IgA nephropathy. The accurate diagnosis of SS was established based on objective signs and symptoms of ocular and oral dryness, a characteristic appearance of a biopsy sample from a minor salivary gland, and the presence of anti-SS-A autoantibody. A second autoimmune disorder was not present, so the diagnosis of primary SS was established. A histologic finding of skin biopsy of purpuric lesion was typical for leukocytoclastic vasculitis. Renal biopsy was performed for nephrotic range proteinuria. The pathologic finding of renal biopsy was IgA glomerulonephritis with crescent formation. The patient was treated with small doses of glucocorticoids and maintenance hemodialysis. Leukocytoclastic vasculitis is one of the most characteristic extraglandular manifestations of SS. However, IgA nephropathy associated with SS and leukocytoclastic vasculitis is a rare finding. SS patients with glomerulonephritis present a more diverse outcome, even requiring hemodialysis. Therefore, renal biopsy is warranted in SS with glomerulonephritis and systemic vasculitis.


Subject(s)
Glomerulonephritis, IGA/complications , Sjogren's Syndrome/complications , Vasculitis, Leukocytoclastic, Cutaneous/complications , Adrenal Cortex Hormones/therapeutic use , Aged , Biopsy, Needle , Female , Follow-Up Studies , Glomerulonephritis, IGA/diagnosis , Glomerulonephritis, IGA/therapy , Humans , Immunohistochemistry , Kidney Function Tests , Renal Dialysis/methods , Risk Assessment , Severity of Illness Index , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/therapy , Treatment Outcome , Vasculitis, Leukocytoclastic, Cutaneous/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/therapy
14.
Ren Fail ; 30(3): 297-301, 2008.
Article in English | MEDLINE | ID: mdl-18350449

ABSTRACT

BACKGROUND: Peritonitis is a common complication of end stage renal failure (ESRF) patients receiving continuous ambulatory peritoneal dialysis (CAPD). Peritoneal macrophage may participate in the activation of specific T cells and in the generation of local cell-mediated immunity to various pathogens. The purpose of this study is to investigate the possible role of macrophage in CAPD patients with peritonitis. METHODS: We evaluated the expression of Fas receptor (CD95), ICAM-1 (CD54), CD25, and CD69 by two-color flow cytometry on extravasted macrophages from 16 ESRF patients on CAPD with peritonitis (peritonitis-positive) and compared them to 11 ESRF patients on CAPD without peritonitis (peritonitis-negative) and normal controls. RESULTS: We found an increased expression of CD95, CD54, and CD25 on macrophage in peritonitis-positive group compared to controls (all p < 0.001). In the peritonitis-positive group, the CD95 expression was significantly higher than that of the peritonitis-negative group (p < 0.001). The expression of CD54, CD25, and CD69, however, was not significantly different between the peritonitis-positive and peritonitis-negative CAPD subgroups. CONCLUSION: We found an abnormally increased percentage of macrophage-expressing Fas receptor and ICAM-1, and the percentage of CD95+ macrophage, but not those of other markers, were increased among the subset of CAPD patients with peritonitis. The later finding suggests that this macrophage phenotype is associated with peritonitis occurring in CAPD.


Subject(s)
Macrophages, Peritoneal/metabolism , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/metabolism , fas Receptor/metabolism , Adult , Aged , Antigens, CD/metabolism , Antigens, Differentiation, T-Lymphocyte/metabolism , Female , Humans , Intercellular Adhesion Molecule-1/metabolism , Interleukin-2 Receptor alpha Subunit/metabolism , Kidney Failure, Chronic/therapy , Lectins, C-Type , Male , Middle Aged , Peritonitis/etiology , Peritonitis/immunology
15.
Ren Fail ; 29(6): 661-5, 2007.
Article in English | MEDLINE | ID: mdl-17763159

ABSTRACT

BACKGROUND: Hyperammonemia caused by ornithine transcarbamylase (OTC) deficiency can be properly managed by continuous arteriovenous hemodiafiltration (CAVHDF). Removal of amino acids (AA) during CAVHDF has not been thoroughly investigated. AA losses in patients with urea cycle defects due to ornithine transcarbamylase deficiency treated by CAVHDF were analyzed. METHODS: Twelve neonates with elevated serum ammonia levels, confirmed through urine organic acid analysis and serum amino acid studies, were documented to have OTC deficiency. CAVHDF was administered in an attempt to lower serum ammonia concentration. Amino acid analysis of ultrafiltration and serum were performed by liquid chromatography. RESULTS: Serum levels of leucine, isoleucine, methionine, phenylalanine, and tyrosine were significantly lower than acceptable in these patients. Glutamine was the only amino acid that increased significantly, which is clinically relevant to OTC enzyme deficiency. Although the mean serum concentrations of tyrosine and glutamine concentrations were lower in the dialysate, the serum and dialysate concentrations of other amino acids did not differ. CONCLUSION: CAVHDF may induce changes in amino acid metabolism and distribution as well. The requirement of aminogram monitor for amino acid supplementation in urea cycle defect patients is important.


Subject(s)
Amino Acids/blood , Hemofiltration , Hyperammonemia/therapy , Ornithine Carbamoyltransferase Deficiency Disease/complications , Amino Acids/analysis , Dialysis Solutions/chemistry , Humans , Hyperammonemia/blood , Hyperammonemia/etiology , Infant, Newborn , Ornithine Carbamoyltransferase Deficiency Disease/blood
16.
Ren Fail ; 29(6): 751-4, 2007.
Article in English | MEDLINE | ID: mdl-17763173

ABSTRACT

Methylmalonic academia (MMA) is a rare inborn error of branched-chain amino acid metabolism. Therapy consists of a special formulated protein diet, carnitine supplementation, and emergent detoxification during acute decompensation. Continuous hemodiafiltration is a modality choice to treat acute metabolic decompensation in inborn error of metabolism. We report the successful use of continuous hemodiafiltration in the management of acute decompensation in patients with methylmalonic academia. Three male patients were diagnosed with methylmalonic academia with the initial presentation of hyperammonemia. Continuous hemodiafiltration was utilized to treat acute decompensation of metabolic crisis. This approach results in a rapid reduction of systemic toxin levels. Continuous hemodiafiltration should be considered as a treatment modality for symptomatic neonates with MMA where hemodialysis is not feasible.


Subject(s)
Amino Acid Metabolism, Inborn Errors/complications , Hemodiafiltration , Hyperammonemia/therapy , Methylmalonic Acid/blood , Hemofiltration , Humans , Hyperammonemia/etiology , Infant, Newborn , Male
17.
Ren Fail ; 26(4): 355-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15462101

ABSTRACT

Continuous hemofiltration has been used with increasing frequency for treating volume overload and acute renal failure in critically ill, hemodynamically unstable pediatric patients. This retrospective report investigates continuous hemofiltration in pediatric patients, and their survival rate. Sixty children treated between 1999 and 2001 with a diagnosis of acute renal failure and requiring continuous hemofiltration were admitted to this study to determine if pediatric risk of mortality III (PRISM III) scores were an accurate prediction of mortality. PRISM III scores were calculated on the day continuous hemofiltration commenced; mean PRISM III scores of non-survivors were significantly higher than mean scores of survivors. PRISM III scores may be a useful indicator of outcome in children receiving continuous hemofiltration.


Subject(s)
Acute Kidney Injury/mortality , Acute Kidney Injury/therapy , Health Status Indicators , Hemofiltration , Adolescent , Child , Child, Preschool , Critical Illness , Female , Humans , Infant , Infant, Newborn , Length of Stay , Male , Predictive Value of Tests , Retrospective Studies , Survival Rate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...